| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TRxADE HEALTH, INC | CFO, PAO, PFO | Common stock | 71,551 | $77,275 | $1.08 | 13 Dec 2022 | Direct |
| ORAGENICS INC | CEO and CFO | Employee Stock Option (right to buy) | 250,000 | 11 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OGEN | ORAGENICS INC | 11 Dec 2025 | 1 | $0 | 4 | CEO and CFO | 15 Dec 2025, 16:55 |
| OGEN | ORAGENICS INC | 19 Sep 2024 | 1 | $0 | 4 | Chief Financial Officer | 20 Sep 2024, 21:15 |
| OGEN | ORAGENICS INC | 08 Aug 2023 | 1 | $0 | 4 | CFO, Secretary and Treasurer | 10 Aug 2023, 16:30 |
| OGEN | ORAGENICS INC | 07 Mar 2023 | 1 | $0 | 4 | CFO, Secretary and Treasurer | 08 Mar 2023, 15:31 |
| OGEN | ORAGENICS INC | 07 Mar 2023 | 0 | $0 | 3 | CFO, Secretary and Treasurer | 08 Mar 2023, 15:29 |
| MEDS | TRxADE HEALTH, INC | 13 Dec 2022 | 1 | $0 | 4 | CFO, PAO, PFO | 24 Feb 2023, 15:45 |
| MEDS | TRxADE HEALTH, INC | 01 Sep 2022 | 1 | $0 | 4 | CFO, PAO, PFO | 16 Sep 2022, 17:17 |
| MEDS | TRxADE HEALTH, INC | 02 Apr 2022 | 0 | $0 | 3 | CFO, PAO, PFO | 04 Apr 2022, 16:35 |